ArticleJournal of cellular and molecular medicine2026
Quantitative and Targeted Regulation of Ferroptosis in Bladder Cancer: Preclinical Study.
Ying Dong, Chaojie Xu, Bing Yan, Shuanzhu Mou, Chen Li, Yuchen Liu
Abstract read
In one paragraphArticle in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Ying DongShenzhen University Medical School, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen University, Shenzhen, China.ORCID 0009-0008-5643-8462 Chaojie XuDepartment of Urology, Peking University First Hospital, Peking University, Beijing, China.ORCID 0000-0001-9609-1848 Bing YanShenzhen Institute of Translational Medicine, Urology of Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China.
Shuanzhu MouShenzhen Institute of Translational Medicine, Urology of Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China.
Chen LiDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuchen LiuShenzhen Institute of Translational Medicine, Urology of Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen University, Shenzhen, China.ORCID 0000-0002-6517-0022 Funding
National Key R&D Program of China 2021YFA0911600Shenzhen Science and Technology Program JCYJ20220818102001002Shenzhen Science and Technology Program RCJC20221008092723011
6 · The paper itselfAbstract
The activation of ferroptosis, a cell death mechanism driven by excessive ferrous ions (Fe
Indexed as
Beclin-1FerroptosisUrinary Bladder NeoplasmsAmino Acid Transport System y+AnimalsCell Line, TumorCell ProliferationCRISPR-Cas SystemsFemaleGene Expression Regulation, NeoplasticHumansMicePhospholipid Hydroperoxide Glutathione PeroxidaseAmino Acid Transport System y+Beclin-1Phospholipid Hydroperoxide Glutathione PeroxidaseSLC7A11 protein, humanBECN1bladder cancerCRISPR‐dCas9ferroptosishTERTOTUB1
Identifiers
PMID42644396
PMCPMC13508133
What OpenQuestion holds
Textmetadata
Read underepoch 390